Living organisms produce a diversity of defense proteins to protect themselves from invading microbes, pathogens, and other noxious organisms. The defense proteins comprise antifungal proteins [@bib1], antimicrobial proteins [@bib2], ribosome inactivating proteins [@bib3], [@bib4], lectins [@bib1], [@bib5], ribonucleases [@bib6] and protease inhibitors [@bib7], [@bib8].

Antifungal proteins are produced by a diversity of organisms including animals [@bib9], plants [@bib1], [@bib2], [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], [@bib8] and fungi [@bib10]. In plants, various tissues including bulbs [@bib11], fruits [@bib12], leaves [@bib13], roots [@bib14], seeds [@bib1], [@bib2], [@bib3], [@bib7], and tubers [@bib5] produce antifungal proteins and peptides. Plant antifungal proteins constitute a repertoire of different proteins [@bib15]. They include chitinases and chitinase-like proteins [@bib5], [@bib14], [@bib16], chitin-binding proteins [@bib1], [@bib13], lipid transfer proteins [@bib2], [@bib17], protease inhibitors [@bib7], [@bib8] ribosome inactivating proteins [@bib3], [@bib4], thaumatin-like proteins [@bib12], [@bib18], glucanases [@bib16], embryo abundant protein-like proteins [@bib19], and defensin-like peptides [@bib20].

From plants belonging to the genus *Brassica*, various proteins including napins [@bib21] and a number of enzymes including amine oxidase [@bib22], pyruvate kinase [@bib23], phosphoenolpyruvate carboxylase [@bib24], myrosinase [@bib25] and glyoxalase [@bib26] have been purified. However, antifungal proteins have been isolated from only several *Brassica* species [@bib17], [@bib27], [@bib28], [@bib29]. Recently, a lipid transfer protein with antifungal activity, referred to hereinafter as BCLTP, has been reported from *Brassica campestris* seeds [@bib17]. Another antifungal peptide with N-terminal sequence similar to *B. napus* trypsin inhibitor but without trypsin inhibitory activity has been isolated from the seeds of *B. parachinensis* [@bib27]. Alboglabrin is an antifungal peptide from *B. alboglabra* seeds with an N-terminal sequence different from those of *B. campestris* and *B. parachinensis* [@bib28]. It is known that the same seed may produce more than one type of antifungal proteins [@bib30]. The intent of the present investigation was to isolate and characterize an additional antifungal protein from *B. campestris* seeds and to ascertain if the antifungal protein is different from the previously isolated lipid transfer peptide [@bib29]. It was found that the isolated peptide displayed various kinds of antipathogenic activities including antifungal, antitumor and anti-HIV reverse transcriptase which are of potential therapeutic value. The peptide, which could be synthesized, is of special interest because the aforementioned activities are thermostable and its antifungal activity is pH-stable.

Materials and methods
=====================

Materials
---------

Seeds of *B. campestris* L. var. purpurea Bailey were purchased from a local vendor, Beijing Seed Company, in Mainland China. The seeds have been authenticated by Prof. Shiuying Hu, Honorary Professor of Chinese medicine, CUHK. They were deposited in laboratory 302, Department of Biochemistry, CUHK, under the voucher number BC883. The fungi were provided by Department of Microbiology, China Agricultural University, China. SP-Sepharose, Mono S column and Superdex Peptide column were from GE Healthcare (Sweden), Affi-gel blue gel was from Bio-Rad (USA). All chemicals were of the highest purity available.

Isolation of antifungal peptides
--------------------------------

The seeds of *B. campestris* L. var. purpurea Bailey were purchased from a local vendor. The crude seed extract was subjected to ion exchange chromatography on a 5 × 20 cm column of Q-Sepharose (GE healthcare) which had been equilibrated with and was then eluted with 10 mM Tris--HCl buffer (pH 7.8). After unadsorbed proteins (fraction Q1) had come off the column, the column was eluted with 10 mM Tris--HCl buffer (pH 7.8) containing 1 M NaCl to yield fraction Q2. Fraction Q1 was then chromatographed on a 2.5 × 20 cm column of Affi-gel blue gel (Bio-Rad) in 10 mM Tris--HCl buffer (pH 7.8). Unadsorbed proteins (fraction B1) were eluted with the same buffer while adsorbed proteins (fraction B2) were eluted with 10 mM Tris--HCl buffer (pH 7.8) containing 1 M NaCl. Fraction B2 was taken for purification on a Mono S column by FPLC in 10 mM NH~4~OAc buffer (pH 4.5). After removal of the unadsorbed proteins, adsorbed proteins were eluted by three successive linear NaCl concentration gradients: 0--0.2 M, 0.2--0.4 M and 0.4--1 M. Fraction S5 eluted by the first gradient was subjected to purification on a Superdex 75 HR 10/30 column (GE healthcare) in 10 mM NH~4~OAc buffer (pH 4.5). Fraction SU3 from the column was purified on a Superdex Peptide column (GE Healthcare). The main resulting peak constituted purified antifungal peptide.

Protein determination
---------------------

Protein concentration was determined by the dye-binding method (Bio-Rad) using bovine serum albumin as a standard.

Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis \[Tricine-SDS-PAGE\]
--------------------------------------------------------------------------------------

It was conducted according to the method of Schagger and von Jagow [@bib31]. After electrophoresis using 18% acrylamide gel, the gel was stained with Coomassie Brilliant Blue. The molecular mass of the isolated antifungal peptide was determined by comparison of its electrophoretic mobility with those of Kaleidoscope prestained standards (Bio-Rad) including carbonic anhydrase, soybean trypsin inhibitor, lysozyme, aprotinin and insulin with molecular mass of 38.8 kDa, 25 kDa, 16.3 kDa, 7.8 kDa and 3.4 kDa, respectively.

N-terminal amino acid sequence analysis
---------------------------------------

The N-terminal amino acid sequence of the purified peptide was determined by Edman degradation using an amino acid sequencer.

Assay of antifungal activity
----------------------------

The assay for antifungal activity was performed using 100 × 15 mm petri dishes containing 10 ml of potato dextrose agar. After the mycelial colony had developed, sterile blank paper disks (0.625 cm in diameter) were placed around and at a distance of 1 cm away from the periphery of the mycelial colony. An aliquot (8 μl containing 60 μg or 300 μg) of the purified peptide in 20 mM PBS buffer (pH 6.0) was added to a disk. The plates were incubated at 23 °C for 72 h until mycelial growth had surrounded peripheral disks containing the control (buffer) and had produced crescents of inhibition around disks containing samples with antifungal activity. The fungal species included *Fusarium oxysporum* and *Mycosphaerella arachidicola* [@bib19].

To determine the IC~50~ value for the antifungal activity of the isolated antifungal peptide, four doses of the peptide were added separately to four aliquots each containing 4 ml potato dextrose agar at 45 °C, mixed quickly and poured into four separate small Petri dishes. After the agar had cooled down the same amount of mycelia was added to each plate. Buffer only without antifungal peptide served as a control. After incubation at 23 °C for 72 h, the area of the mycelial colony was measured and the inhibition of fungal growth determined. The concentration of the isolated antifungal peptide that brought about 50% reduction in the area of mycelial colony is the IC~50~ [@bib19].

To investigate the thermal \[0--100 °C\] stability and pH \[pH 0--14\] stability of the antifungal activity, the isolated antifungal peptide was pretreated for 30 min accordingly and the antifungal assay was then conducted as mentioned above. After thermal treatment, the antifungal peptide solution in 10 mM Tris--HCl buffer (pH 7.8) was cooled down to room temperature before the assay for antifungal activity. After pH treatment, the low-molecular-weight components in the mixture were removed by centricon (Millipore) and pH adjusted to 7.8 using Tris--HCl buffer.

A solution of the isolated antifungal peptide \[1 mg/ml\] was incubated with an equal volume of trypsin or pepsin \[1 mg/ml\] at 37 °C for 1 h. At the end of the incubation, the reaction mixture was examined for antifungal activity.

Assay of lipid binding
----------------------

Binding of lysolecithin was conducted at 25 °C with a Carywin-100 spectrofluorimeter (Varian Ltd, USA). The excitation wavelength was at 229 nm and emission spectra were recorded from 300 to 400 nm with 4-nm bandwidths and were corrected for the buffer contribution. Small amounts of concentrated lyso-C~12~ (lyso-α-lauroyl-phosphatidylcholine) solution in water (5 mg/ml) were added stepwise to a cuvet containing 1 ml of a solution of the isolated antifungal peptide (0.25 mg/ml) in 20 mM Tris--HCl buffer (pH 7.8). For each lipid--protein ratio, the maximum fluorescence intensity at 329 nm was used for constructing lipid titration curves. This maximum intensity was determined by averaging the intensity values obtained at 328 nm, 329 nm and 330 nm [@bib29]. To investigate the thermal \[0--100°C\] stability of the lipid binding activity, the isolated antifungal peptide was pretreated for 30 min accordingly and the assay was then conducted as mentioned above.

Assay of antiproliferative activity on tumor cell lines
-------------------------------------------------------

This assay was performed in view of reports that some antifungal proteins have this activity [@bib20], [@bib29]. Breast cancer MCF-7 cells, heptoma HepG2 cells and normal human embryonic liver cells WRL68 were suspended in RPMI medium and the cell density was adjusted to 2 × 10^4^ cells/ml. A 100-μl aliquot of the cell suspension was seeded to a well of a 96-well plate, followed by incubation for 24 h. Different concentrations of the antifungal peptide in 100 μl complete RPMI medium were then added to the wells and incubated for 72 h. After 72 h, 20 μl of 5 mg/ml solution of \[3-\[4,5-of imethylthiazol-2-yl\]-2,5-diphenyltetrazolium bromide\] \[MTT\] in phosphate buffered saline was spiked into each well. The plates were incubated for another 4 h. The plates were then centrifuged at 324 ×*g* for 5 min. The supernatant was carefully removed and 150 μl of dimethyl sulfoxide was added to each well to dissolve the MTT-formazan formed at the bottom of the wells. Ten minutes later, the absorbance at 590 nm was determined by using a microplate reader [@bib20]. Blank was set by adding 100 μl of dimethyl sulfoxide. Negative control was set as 100% of cell survival. To investigate the thermal \[0--100 °C\] stability of the antiproliferative activity, the isolated antifungal peptide was pretreated for 30 min accordingly and the assay was then conducted as mentioned above.

Assay for HIV-1 reverse transcriptase inhibitory activity
---------------------------------------------------------

The assay for HIV reverse transcriptase inhibitory activity was conducted in accordance with procedures supplied with the assay kit from Boehringer Mannheim (Germany) was carried out since some antifungal proteins possess this activity [@bib8], [@bib11], [@bib20], [@bib29]. The assay makes use of the ability of reverse transcriptase to synthesize DNA, starting from the template/primer hybrid poly (A) oligo (dT) 15. The digoxigenin- and biotin-labeled nucleotides in an optimized ratio are incorporated into one of the same DNA molecule, which is freshly synthesized by the reverse transcriptase (RT). The detection and quantification of synthesized DNA as a parameter for RT activity follows a sandwich ELISA protocol. Biotin-labeled DNA binds to the surface of streptavidin-precoated microtiter plate modules. In the next step, a precoated antibody to digoxigenin, conjugated to peroxidase, binds to the digoxigenin-labeled DNA. In the final step, the peroxidase substrate is added. The peroxidase enzyme catalyzes the cleavage of the substrate, forming a colored reaction product. The absorbance of the sample at 405 nm can be measured using a microtiter plate (ELISA) reader and is directly correlated to the level of RT activity. A fixed amount (4--6 ng) of recombinant HIV-1 reverse transcriptase was used. The inhibitory activity of the antifungal peptide was calculated as percent inhibition as compared to a control without the antifungal peptide [@bib11]. To investigate the thermal \[0--100 °C\] stability of HIV-1 reverse transcriptase inhibitory activity, the isolated antifungal peptide was pretreated for 30 min accordingly and the assay was then conducted as mentioned above.

Assay of ability to inhibit HIV-1 integrase
-------------------------------------------

The assay was carried out since some antifungal proteins possess this activity [@bib32].

### Expression and purification of recombinant HiV-1 integrase

The plasmid that expressed His-tagged wild-type HIV-1 integrase, pT7-7-His (Y\|TX)-HIV-1-IN, was a generous gift from Dr. S.A. Chow (School of Medicine, UCLA). To express the protein, a 1-liter culture of *E. coli* BL21 (DE3) cells containing the expression plasmid was grown at 37 °C until OD~600~ reached 0.7--0.8. Cells were induced by addition of 0.8 mM IPTG and harvested after 4 h incubation by centrifugation at 6000 ×*g* for 10 min at 4 °C. Cells were suspended at a concentration of 10 ml/g wet cell paste in 20 mM Tris--HCl (pH 8.0), containing 0.1 mM EDTA, 2 mM β-mercaptoethanol, 0.5 M NaCl and 5 mM imidazole. Lysozyme was added to a concentration of 0.2 mg/ml. After 1 h incubation at 4 °C, the lysate was sonicated and centrifuged at 40,000 ×*g* at 4 °C for 20 min. The pellet was homogenized in 50 ml buffer A (20 mM Tris--HCl, pH 8.0, 2 M NaCl, 2 mM β-mercaptoethanol) containing 5 mM imidazole. The suspension was rotated at 4 °C for 1 h and cleared by centrifugation at 40,000 ×*g* at 4 °C for 20 min. The supernatant was loaded onto a 1 ml chelating Sepharose column charged with 50 mM imidazole. The column was washed with five column volumes of buffer A containing 5 mM imidazole and the protein was eluted with three column volumes of buffer A containing 200 mM and 400 mM imidazole, respectively. Protein-containing fractions were pooled and EDTA was added to a final concentration of 5 mM. The protein was dialyzed against buffer B (20 mM HEPES, pH 7.5, 1 mM EDTA, 1 M NaCl, 20% glycerol) containing 2 mM β-mercaptoethanol and then against buffer B containing 1 mM dithiothreitol. Aliquots of the protein were stored at − 70 °C.

### HIV-1 integrase assay

A non-radioactive ELISA-based HIV-1 integrase assay was performed according to the DNA-coated plates method. In this study, 1 μg of *Smal*-linearized p Bluescript SK was coated onto each well in the presence of 2 M NaCl as target DNA. The donor DNA was prepared by annealing VU5BR (5′-biotin-GTGTGGAAAATCTCTAGCAGT-3′) and VU5 (5′-ACTGCTAGAGATTTTCCACAC-3′) in 10 mM Tris-HC1, pH 8.0, 1 mM EDTA and 0.1 M NaCl at 80 °C followed by 30 min at room temperature. Integrase reaction was performed in 20 mM HEPES (pH 7.5), containing 10 mM MnCl~2~, 30 mM NaCl, 10 mM dithiothreitol and 0.05% Nonidet-P40 (Sigma). After the integrase reaction, the biotinylated DNA immobilized on the wells was detected by incubation with streptavidin-conjugated alkaline phosphatase (Boehringer Mannheim) followed by colorimetric detection with 1 mg/ml *p*-nitrophenyl phosphate in 10% diethanolamine buffer, pH 9.8, containing 0.5 mM MgCl~2~. The absorbance due to the alkaline phosphatase reaction was measured at 415 nm. The ribosome inactivating protein trichosanthin was used as a positive control [@bib32], [@bib33].

Screening for inhibitory effect on SARS Coronavirus (CoV) protease
------------------------------------------------------------------

Some antifungal proteins have been tested for this activity [@bib33]. The activity of SARS CoV protease was indicated by a designed substrate which was composed of two proteins linked by a cleavage site for SARS CoV protease. The substrate for assay is a recombinant protein that has a cleavable linker sequence (TSAVLQ↓SGFRK) between two fluorescent proteins, viz cyan fluorescent protein (CFP) and yellow fluorescent protein (YFP). The former one is the donor protein of which the emission spectrum overlaps with the excitation spectrum of the latter acceptor protein. The reaction was performed in a mixture containing 5 μM SARS CoV protease, 5 μM sample, 20 μM substrate and buffer (20 mM Tris--HCl (pH7.5), 20 mM NaCl and 10 mM beta-mercaptoethanol) for 40 min at 37 °C. After 40 min, the reaction was stopped by heating at 100 °C for 2 min. Then the reaction mixture was analyzed by SDS-PAGE. If SARS CoV protease is inhibited by the test sample, there is only one band, which is the intact substrate, shown in the SDS-PAGE.

Assay for trypsin-inhibitory activity
-------------------------------------

This assay was conducted in view of the finding that some antifungal proteins have trypsin inhibitory activity [@bib8] and that *B. parachinensis* antifungal peptide has an N-terminal sequence similar to a trypsin inhibitor [@bib27]. Trypsin activity was determined by using N-α-benzoyl-[l]{.smallcaps}-arginine ethyl ester hydrochloride (BAEE) as the substrate. Ten microliters of a trypsin solution (250 μg/ml) in assay buffer (50 mM Tris--HCl, pH 8, containing 20 mM CaCl~2~) were added to 980 μl of assay buffer and then 10 μl of BAEE in assay buffer was added to give a final concentration of 0.6 mM. The reaction rate was determined by monitoring the absorbance change at 253 nm for 1 min.

To assay for trypsin-inhibitory activity, 10 μl test sample in assay buffer was added to trypsin, and incubated at 25 °C for 15 min before addition of substrate (BAEE) to initiate the reaction. Trypsin-inhibitory activity was calculated as follows:$$Trypsin - inhibitory\, activity\,\left( U \right) = \frac{Abs\, control - Abs\, sample}{Abs\, control \times trypsin\,\left( {mg} \right)}$$where Abs control is absorbance change in absence of sample, Abs sample is absorbance change in presence of sample, trypsin (mg) is the amount of trypsin in assay mixture. One unit of trypsin-inhibitory activity refers to the activity capable of inhibiting 1 mg trypsin. A similar assay was conducted using casein as substrate instead of BAEE [@bib8].

Assay of mitogenic activity
---------------------------

This assay was carried out since some antifungal proteins possess this activity [@bib20]. Four C57BL/6 mice \[20--25 g\] were sacrificed by cervical dislocation. The spleens were removed aseptically and spleen cells were isolated by pressing the tissue through a sterilized 100-mesh stainless steel sieve and resuspended to 5 × 10^6^ cells/ml in RPMI 1640 culture medium supplemented with 10% fetal bovine serum, 100 U penicillin/ml, and 100 μg streptomycin/ml. The cells \[7 × 10^5^ cells/100 μl/well\] were seeded into a 96-well culture plate. Serial dilutions of a solution of the isolated peptide in 100 μl medium were added. After incubation of the cells at 37 °C in a humidified atmosphere of 5% CO~2~ for 24 h, 10 μl \[methyl-^3^H\]-thymidine \[0.25 μCi, GE Healthcare\] was added. The cells were incubated for a further 6 h under the same conditions. The cells were then harvested with an automated cell harvester onto a glass fiber filter. The radioactivity was measured with a Beckman model LS 6000SC scintillation counter. All reported values are the means of triplicate samples. Con A was used as positive control and bovine serum albumin as a negative control [@bib20].

Results
=======

Isolation of campesin and determination of molecular mass and N-terminal sequence
---------------------------------------------------------------------------------

The crude seed extract was fractionated by ion exchange chromatography on Q-Sepharose to produce a large unadsorbed fraction Q1 with antifungal activity and a sharp adsorbed fraction Q2 devoid of antifungal activity. Affinity chromatography of fraction Q1 on Affi-gel blue gel yielded a broad unadsorbed fraction B1 without antifungal activity and a smaller adsorbed fraction B2 with antifungal activity. The results have been shown in a previous publication \[17\]. FPLC-ion exchange chromatography of fraction B2 on Mono S gave rise to several fractions ([Fig. 1](#fig1){ref-type="fig"}A). Purification of fraction S5 with antifungal activity was performed by gel filtration on a Superdex 75 column to yield a large peak (SU3) two small peaks (SU1 and SU2) ([Fig. 1](#fig1){ref-type="fig"}B). Fraction SU3 with antifungal activity was purified on a Superdex peptide column to yield a large absorbance peak with antifungal activity (P1) and a tiny inactive peak ([Fig. 1](#fig1){ref-type="fig"}C). The yields of crude extract, fractions Q1, B2, S5, SU3 and P1 from 400 g seeds were 19430, 7310, 850, 40, 25 and 20 mg, respectively ([Table 1](#tbl1){ref-type="table"} ). Fraction P1, the purified peptide, showed a molecular mass of 9.4 Da in Tricine-SDS-PAGE ([Fig. 2](#fig2){ref-type="fig"} ) and 9.4 kDa in gel filtration on Superdex peptide ([Fig. 1](#fig1){ref-type="fig"}C). It resembled the previously reported *B. campestris* lipid transfer peptide (BCLTP) in N-terminal sequence ([Table 2](#tbl2){ref-type="table"} ).Fig. 1(A) FPLC-ion exchange chromatography on Mono S. Sample: fraction of seed extract previously adsorbed on Q-Sepharose and subsequently adsorbed on Affi-gel blue gel. Fraction S5 with antifungal activity was collected. (B) Gel filtration on a Superdex 75 HR 10/30 column. Fraction SU3 with antifungal activity was collected. (C) Gel filtration on a Superdex Peptide column. Fraction P1 with antifungal activity was collected.Table 1Summary of purification of campesin from the seed *Brassica campestris*.ContentActive chromatographic fractionYield (mg) from 400 g seeds--Crude extract19430Q-SepharoseQ17310Affi-gel Blue gelB2850Mono SS540Superdex 75SU125Superdex PeptideP120Fig. 2Tricine-SDS-PAGE of campesin. Left lane: molecular Kaleidoscope prestained molecular standards including carbonic anhydrase, soybean trypsin inhibitor, lysozyme, aprotinin and insulin with molecular mass of 38.8 kDa, 25 kDa, 16.3 kDa, 7.8 kDa and 3.4 kDa, respectively. Right lane: campesin.Table 2N-terminal sequence of campesin in comparison with other *Brassica* antifungal peptides.N-terminal sequenceCampesin (this study)^1^ALSCGTVSAQIAACAGYV^18^*BCLTP*[@bib29]^1^ALSCGTVSGNLAACAGYV^18^*Brassica alboglabra* antifungal peptide [@bib28]^1^PEGPFQGPKATKPGDLAXQTWGGWXGQTPKY^31^*Brassica parachinensis* antifungal peptide ([@bib27])[a](#tblfn1){ref-type="table-fn"}^1^DQFPQEYPGDVQFSFNALHIYPSPQVVVI^29^[^1][^2]

Biological activities of campesin
---------------------------------

The peptide exerted antifungal activity against various fungal species including *M. arachidicola* (A) and *F. oxysporum* (B) with the IC~50~ values being respectively 4.4 μM (A) and 5.1 μM (B) ([Fig. 3](#fig3){ref-type="fig"} ). Its lipid transfer activity is shown in [Fig. 4](#fig4){ref-type="fig"} . The antifungal activity of the peptide was retained after exposure to trypsin, chymotrypsin and pepsin, and to various temperatures from 0 °C to 100 °C, and to the pH range 0--14. It inhibited proliferation of HepG2 cells and MCF7 cells ([Fig. 5](#fig5){ref-type="fig"}A) with an IC~50~ of 6.4 μM and 1.8 μM, respectively, and reduced the activity of HIV-1 reverse transcriptase with an IC~50~ of 3.2 μM ([Fig. 5](#fig5){ref-type="fig"}B). However, there was no antiproliferative activity toward normal embryonic liver WRL68 cells ([Fig. 5](#fig5){ref-type="fig"}A). The antiproliferative and HIV-1 reverse transcriptase inhibitory activities were fully preserved after exposure to various temperatures from 0 °C to 100 °C for 30 min. For the purpose of comparison, the thermostability of the various activities of BCLTP which had not previously been examined, was tested and the activities were found to be completely preserved at various temperatures from 0 °C to 100 °C. [Table 3](#tbl3){ref-type="table"} shows a comparison of the antifungal peptides from various *Brassica* species. It lacked trypsin inhibitory activity toward casein and BAEE when tested up to 10 μM and 50 μM, respectively (not shown). It was devoid of mitogenic activity ([Fig. 5](#fig5){ref-type="fig"}C). However, it had no inhibitory effect on HIV-1 integrase and SARS proteinase (not shown).Fig. 3Determination of IC~50~ of antifungal activity of campesin. The fungi tested were: plate (A) *Mycosphaerella arachidicola* and (B) *Fusarium oxysporum*. (C) shows concentration of campesin in each plate.Fig. 4Comparison of increase in fluorescence intensity at 329 nm on lysolecithin binding due to campesin and BCLTP. *F*--*F*~0~ represents the fluorescence intensity of campesin. *F* is the intensity obtained at each lipid--protein ratio.Fig. 5Campesin demonstrated antiproliferative activity (A), and HIV-1 reverse transcriptase inhibitory activity (B), but lacked mitogenic activity (C). Results represent mean ± SD (*n* = 3).Table 3Comparison with other *Brassica* antifungal peptides.Campesin*, (B. campestris* (this study)BCLTP (*B. campestris*) [@bib29]Antifungal peptide (*B. alboglabra)*[@bib28]Antifungal peptide (*B. parachinensis)* ([@bib27])[a](#tblfn2){ref-type="table-fn"}Molecular weight9.4 kDa9414 Da5907 Da5716 DaLipid transfer activityPresentPresentAbsentAbsentAntifungal activity (IC~50~)*Mycosphaerella arachidicola*: 4.4 μM*M. arachidicola*: 8.3 μM*M. arachidicola*: 2.4 μM*M. arachidicola*: 2.6 μM*Fusarium oxysporum*: 5.1 μM*F. oxysporum*: 4.5 μM*F. oxysporum*: 4.3 μM*F. oxysporum*: 3.9 μMAntitumor activity (IC~50~)HepG2: 6.4 μMHepG2: 5.8 μMHepG2: 2.7 μMHepG2: 19.2 μMMCF7: 1.8 μMMCF7: 1.6 μMMCF7: 3.4 μMMCF7: 4.8 μMAntiproliferative activity on normal human embryonic liver cells (WRL68)Devoid of activityNot testedNot testedNot testedAnti-HIV reverse transcriptase activity (IC~50~)3.2 μM4 μM4.9 μM17.8 μMpH stability of antifungal activityStable from pH 0--14Stable from pH 0--14Stable from pH 2--11Stable from pH 1--13ThermostabilityUp to 100 °C (shown for all aforementioned activities)Up to 100 °C (shown for all aforementioned activities)Up to 80 °C (shown for antifungal activity only)Up to 100 °C (shown for antifungal activity only)[^3][^4]

Discussion
==========

An antifungal peptide (BCLTP) with a molecular mass of 9414 Da and an N-terminal sequence similar to nonspecific lipid transfer proteins has previously been isolated from *B. campestris* seeds [@bib29]. The present study constitutes another report on the isolation of an antifungal peptide from seeds of the same species. Nevertheless, the N-terminal sequence of the antifungal peptide isolated in the present study, designated as campesin, is similar to that of BCLTP except for the replacement of some amino acids in BCLTP by more basic residues but different from those of antifungal peptides from *B. parachinensis* and *B. alloglabra* although all of them demonstrate pronounced thermostability and pH stability, HIV-1 reverse transcriptase inhibitory activity and antiproliferative activity toward tumor cells. They exert antifungal activity toward a variety of fungal species including *F. oxysporum*, *M. arachidicola* and a *Helminthosporium* species. *Brassica parachinensis* napin shows N-terminal sequence similarity to *B. napus* trypsin inhibitor as well as trypsin inhibitory activity [@bib21]. *B. parachinensis* antifungal peptide also exhibits N-terminal sequence to trypsin inhibitor but it is devoid of trypsin inhibitory activity [@bib27]. The absence of trypsin inhibitory activity in *B. parachinensis* antifungal peptide in spite of N-terminal sequence similarity to trypsin inhibitors is reminiscent of the lack of antifungal activity of thaumatin despite the fact that thaumatin-like proteins have antifungal activity [@bib18]. However, campesin does not resemble napin in N-terminal sequence and manifests no trypsin inhibitory activity. This is noteworthy in view of the fact that some of the trypsin inhibitors demonstrate antifungal activity [@bib8]. The two *B. campestris* antifungal peptides, campesin and BCLTP were isolated by using similar protocols. Ion exchange chromatography on Q-Sepharose, affinity chromatography on Affi-gel blue gel, ion exchange chromatography on Mono S and gel filtration on Superdex Peptide were used for purification of *B. campestris* lipid transfer peptide [@bib29], the only difference in the present protocol being an additional gel filtration on Superdex 75.

The yield of campesin (50 mg/kg) is lower than that of BCLTP (175 mg/kg). The HIV-1 reverse transcriptase inhibitory activity of the former (IC~50~  = 3.2 μM) is also lower than that of the latter (IC~50~  = 4 μM) but more potent than many anti-HIV-1 natural products [@bib32]. Similarly, the antiproliferative activity of campesin toward HepG2 cells and MCF-7 cells (IC~50~  = 6.4 μM and 1.8 μM, respectively) is lower than that of BCLTP (IC~50~  = 5.8 μM and 1.6 μM, respectively). Both antifungal peptides are devoid of mitogenic activity toward mouse splenocytes. It has previously been shown that some [@bib8], [@bib20] but not other [@bib29] antifungal proteins/peptides exhibit mitogenic activity. BCLTP and campesin have similar lipid transfer activity. They have no inhibitory effect on HIV-1 integrase, unlike some other antifungal proteins [@bib32]. They are also inactive toward SARS proteinase. French bean defensin-like antifungal peptides resemble BCLTP and campesin in that all of them do not have any suppressive effect on HIV-1 integrase and SARS CoV proteinase [@bib33].

Lysolecithin is employed as a model phospholipid for lipid transfer activity assay in this study since it manifests in aqueous solution a simple and quick equilibrium between dispersed monomeric molecules and micellar aggregates. Lipid binding by nsLTPs, in aqueous solution by fluorescence spectroscopy with substrate lyso-C~12~, was first studied using maize nsLTP and wheat nsLTP [@bib34]. The relative enhancement fluorescence intensity of campesin shows similarity to that of wheat nsLTP, while maize nsLTP evokes a considerably smaller relative increase [@bib35]. The presence of a stable lysolecithin--protein complex in aqueous solution is analogous to a condition in which nsLTP serves as a carrier that can extract one lipid molecule from a membrane and transfer it to another [@bib36]. The results disclose that the relative increase of fluorescence intensity continues as lipid/protein ratio rises until a plateau is attained, indicating that the purified peptide possesses good lipid transfer activity. To date, it has been impossible to isolate a stable complex involving lysolecithin and to establish the model of binding of such a molecule to the nsLTP. Recent monolayer experiments [@bib34] provide addition information on the interaction between the wheat nsLTP and diacylphospholipids. A model is proposed involving a collisional complex-shuttle mechanism. In this model, only one acyl chain of the lipid is inserted into the protein hydrophobic tunnel and the transfer implies an intimate contact between the donor and acceptor membranes to prevent transfer of the second acyl chain in the aqueous solvent. Ongoing studies aim to establish more precisely the binding mode of multiacyl phospholipids by nsLTPs.

The physiological importance of lipid transfer protein in *B. campestris* seeds remains to be clarified although different functions of these proteins have been shown. These comprise surface wax synthesis in leaves [@bib37], lipid reserves mobilization in cotyledons [@bib38], fatty acyl CoA binding [@bib39], calmodulin binding [@bib40], defense reaction [@bib41], protection of thylakoids of nonacclimated plants from freeze--thaw damage [@bib42], and food IgE-mediated allergy [@bib43]. The promoter of a lipid transfer gene is upregulated by blue and red light and viral infection in transgenic *Arabidopsis* [@bib44]. The physiologic significance of nsLTP in *Brassica* seeds is likely to comprise mobilization of lipid reserves during germination [@bib38] and resistance to pathogenic organisms [@bib44].

Lipid transfer proteins with antifungal activity have been demonstrated in only a small number of plants including maize [@bib45], wheat [@bib46], onion [@bib47], sunflower [@bib48], pepper [@bib49], mungbean [@bib50], rice [@bib51], cheeseweed [@bib52], sugar beet [@bib53], and radish [@bib54]. Antifungal activity has not been demonstrated in lipid transfer protein from *Ginkgo biloba* [@bib55] and some lipid transfer protein isoforms from grape [@bib56]. The presence of lipid transfer protein isoforms in *B. campestris* seeds revealed by the present study is in line with the findings on grape [@bib56] although both isoforms in *B. campestris* have antifungal activity whereas only one isoform in grape manifests antifungal activity [@bib56].

Most of the aforementioned lipid transfer proteins have been tested only for antifungal and/or antibacterial activity and the other activities tested in the present investigation were not examined. The antiproliferative activity toward tumor cells and inhibitory activity toward HIV-1 reverse transcriptase observed in both BCLTP and campesin are in line with their role as defense proteins. It is shown only in the present study that campesin is devoid of antiproliferative activity on normal embryonic liver cells. Thus, it appears that its antiproliferative activity is confined to tumor cells. It is also demonstrated that all the biological activities of both BCLTP and campesin are thermostable, while in previous studies only the antifungal activity of the plant lipid transfer proteins has been shown to be thermostable. The peptide nature, and highly potent as well as thermostable antifungal, antitumor and anti-HIV reverse transcriptase activities of both BCLTP and campesin make them candidates for development into therapeutic agents.

In summary, the two antifungal peptides isolated from *B. campestris* seeds (i.e. campesin and BCLTP) have potentially exploitable activities. In contrast, some antifungal proteins like mungbean chitinase lack HIV-1 reverse transcriptase inhibitory activity and antiproliferative activity toward tumor cells [@bib29]. The finding in the present study of two closely similar antifungal peptides is reminiscent of the report of two highly homologous ribosome inactivating proteins with antifungal activity from bitter melon seeds [@bib4]. Other previous investigations revealed the presence of two structurally disparate antifungal proteins in the same plant tissue [@bib30].

[^1]: ^1^P and Y^31^ indicate P and Y being the 1st and 31st residue, respectively.

[^2]: Quota reference: [@bib27], [@bib28], [@bib29].

[^3]: All four antifungal peptides above are devoid of mitogenic, HIV-1 integrase inhibitory and SARS CoV proteinase inhibitory activity.

[^4]: Quota reference: [@bib27], [@bib28], [@bib29].
